Statement of Organization, Functions, and Delegations of Authority, 49302-49304 [2019-20218]
Download as PDF
49302
Federal Register / Vol. 84, No. 182 / Thursday, September 19, 2019 / Notices
SUMMARY OF ANNUAL BURDEN—Continued
Type of burden
Obligation to
respond
Estimated
number of
respondents
Estimated
number of
responses
Estimated
time per
response
(hours)
Frequency of
response
.............................
.............................
....................
....................
....................
..............................
Information collection (IC) description
Total Estimated Annual Burden Hours ..
General Description of Collection: The
Interagency Guidance on Leveraged
Lending (Guidance) outlines for agencysupervised institutions high level
principles related to safe-and sound
leveraged lending activities, including
underwriting considerations, assessing
and documenting enterprise value, risk
management expectations for credits
awaiting distribution, stress testing
expectations, pipeline portfolio
management, and risk management
expectations for exposures held by the
institution.
This Guidance provides information
to all financial institutions supervised
by the Office of the Comptroller of the
Currency, the Board of Governors of the
Federal Reserve System and the FDIC
(the Agencies) that engage in leveraged
lending activities. The number of
community banks with substantial
involvement in leveraged lending is
small; therefore, the Agencies generally
expect community banks to be largely
unaffected by this information
collection. There is no change in the
method or substance of the collection.
The overall reduction in burden hours
is the result of economic fluctuation. In
particular, the number of respondents
has decreased while the hours per
response and frequency of responses
have remained the same.
jbell on DSK3GLQ082PROD with NOTICES
Request for Comment
Comments are invited on: (a) Whether
the collection of information is
necessary for the proper performance of
the FDIC’s functions, including whether
the information has practical utility; (b)
the accuracy of the estimates of the
burden of the information collection,
including the validity of the
methodology and assumptions used; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. All comments will become
a matter of public record.
Dated at Washington, DC, on September
12, 2019.
Valerie Best,
Assistant Executive Secretary.
[FR Doc. 2019–20216 Filed 9–18–19; 8:45 am]
17:30 Sep 18, 2019
Jkt 247001
FEDERAL MARITIME COMMISSION
Notice of Agreements Filed
The Commission hereby gives notice
of the filing of the following agreement
under the Shipping Act of 1984.
Interested parties may submit comments
on the agreement to the Secretary by
email at Secretary@fmc.gov, or by mail,
Federal Maritime Commission,
Washington, DC 20573, within twelve
days of the date this notice appears in
the Federal Register. Copies of
agreements are available through the
Commission’s website (www.fmc.gov) or
by contacting the Office of Agreements
at (202) 523–5793 or tradeanalysis@
fmc.gov.
Agreement No.: 201320.
Agreement Name: CNCO/Matson Slot
Charter Agreement.
Parties: The China Navigation Co. Pte.
Ltd. and Matson Navigation Company,
Inc.
Filing Party: Conte Cicala; Clyde & Co
US LLP.
Synopsis: The Agreement authorizes
China Navigation Company to charter
space to Matson in the trade between
the U.S. Pacific Coast, Samoa, American
Samoa, and Tahiti.
Proposed Effective Date: 9/10/2019.
Location: https://www2.fmc.gov/
FMC.Agreements.Web/Public/
AgreementHistory/23436.
Dated: September 13, 2019.
Rachel E. Dickon,
Secretary.
[FR Doc. 2019–20211 Filed 9–18–19; 8:45 am]
BILLING CODE 6731–AA–P
PO 00000
Frm 00058
Fmt 4703
4,152
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Statement of Organization, Functions,
and Delegations of Authority
BILLING CODE 6714–01–P
Federal Deposit Insurance Corporation.
VerDate Sep<11>2014
Total
estimated
annual
burden
(hours)
Sfmt 4703
Part E, Chapter E (Agency for
Healthcare Research and Quality), of the
Statement of Organization, Functions,
and Delegations of Authority for the
Department of Health and Human
Services (61 FR 15955–58, April 10,
1996, most recently amended at 81 FR
22271, on April 15, 2016) is amended to
reflect recent organizational changes.
The specific amendments are as follows:
I. Under Section E–10, Organization,
delete all components and replace with
the following:
A. Office of the Director.
B. Center for Evidence and Practice
Improvement.
C. Center for Quality Improvement
and Patient Safety.
D. Center for Financing, Access, and
Cost Trends.
E. Office of Communications.
F. Office of Extramural Research,
Education, and Priority Populations.
G. Office of Management Services.
II. Under Section E–20, Functions,
delete Center for Evidence and Practice
Improvement, Center for Quality
Improvement and Patient Safety, Center
for Delivery, Organization, and Markets,
and Center for Financing Access and
Cost Trends in its entirety and replace
with the following:
Center for Evidence and Practice
Improvement. Conducts and supports
research on health care delivery and
practice improvement across the
continuum of care from prevention to
chronic care management to end of life
care. Specifically: (1) Synthesizes
evidence and translates science for
multiple stakeholders; (2) advances
decision and communication sciences to
facilitate informed treatment and health
care decision making by patients and
their health care providers; (3) explores
how health information technology can
improve clinical decision making and
health care quality; (4) catalyzes and
promotes sustainability of
improvements in clinical practice across
health care settings through research,
E:\FR\FM\19SEN1.SGM
19SEN1
jbell on DSK3GLQ082PROD with NOTICES
Federal Register / Vol. 84, No. 182 / Thursday, September 19, 2019 / Notices
demonstration projects, and partnership
development; (5) studies the roles that
health professionals, health systems,
and organizations play in the provision
of health care services; (6) examines the
role of health systems in improving
quality and efficiency of health care
services; and (7) operates the National
Center for Excellence in Primary Care
Research.
Shall be organized into the following
five divisions:
Division of Evidence-Based Practice
Centers: Produces evidence syntheses
by conducting systematic evidence
reviews using robust and rigorous
methodologies and advances the
methods of evidence synthesis to ensure
scientific rigor and unbiased reviews.
Division of U.S. Preventive Services
Task Force: Provides scientific,
administrative, and dissemination
support for the independent U.S.
Preventive Services Task Force,
enabling the Task Force to make
evidence-based recommendations on
clinical preventive services.
Division of Digital Healthcare
Research: Via advanced analytics to
enhance health care decision making,
the division focuses on conducting
research to determine how the parts of
the ever evolving digital health care
ecosystem can best come together to
affect transformational value for patients
and their families in the safe delivery of
care.
Division of Practice Improvement:
Advances the science of clinical
practice improvement including shared
decision making; evaluates and supports
innovative models of practice
transformation in diverse settings;
facilitates communities of learning to
promote the implementation of
evidence for practice improvement; and
serves as a trusted source of evidence
and tools for methods, measures, and
evaluation of practice improvement.
Division of Healthcare Delivery and
Systems Research: Develops new
evidence, tools and measures to
understand how health care is delivered
in the U.S., emphasizing the roles that
physicians, physician practices,
hospitals, health systems, other medical
professionals, and organizations play in
the provision of health care services.
Center for Quality Improvement and
Patient Safety. Measures performance of
the U.S. health care system; identifies,
promotes, and supports evidence-based
research; and provides information that
is used to improve the safety and quality
of health care. Collaborates with
stakeholders across the health care
system to: Implement evidence-based
practices, accelerate and amplify
VerDate Sep<11>2014
17:30 Sep 18, 2019
Jkt 247001
improvements in quality and patient
safety.
Shall be organized into the following
four divisions:
Division of General Patient Safety:
Leads intramural and extramural
research that focuses on the risks and
harms inherent in the delivery of health
care for a variety of conditions in all
health care settings, including the
hospital, ambulatory and long-term care
facilities, and the home. Develops, tests,
and facilitates understanding and use of
evidence-based tools and information to
improve the quality and safety of health
care and reduce the risk of patient harm.
Major topics of research and tool
development include health care
leadership and teamwork, safe
medication use, health care simulation,
diagnostic performance, care
coordination, measurement, patient
safety reporting and surveillance,
detection and analysis, patient and
family engagement, and health care
facility design.
Division of Patient Safety
Organizations: Administers the Patient
Safety Organization (PSO) Program in
accordance with the Patient Safety and
Quality Improvement Act of 2005.
Approves and oversees PSOs that apply
for official federal ‘‘listing.’’ Publishes
Common Formats for measuring adverse
events in hospitals.
Division of Healthcare-Associated
Infections (HAI): Leads AHRQ’s robust
program of research studies and
implementation projects that has two
closely related purposes: To prevent,
reduce, and ultimately eliminate HAIs;
and to combat antibiotic resistance.
Fosters the creation of new knowledge
and the generation of evidence to
develop improved methods for
preventing health care associated
infections and improving antibiotic use
in multiple health care settings,
including hospital acute care, long-term
care, and ambulatory care, and promotes
the wide-scale implementation of
effective interventions for preventing
healthcare-associated infections and
promoting antibiotic stewardship in all
these care settings.
Division of Quality Measurement and
Improvement: Conducts quality
measurement and evaluates
improvement activities in order to
improve healthcare delivered in the
United States. Seeks opportunities to
integrate various measurement efforts in
order to provide a more complete
picture of quality and safety. Promotes
enhanced collaboration and
coordination of measurement efforts,
including integration where possible, in
order to serve the needs of multiple
stakeholders who use measurement,
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
49303
such as front-line clinicians, patients,
safety and quality experts,
administrators, researchers, payers,
policymakers, and others. Conducts
focused measurement programs
including the National Healthcare
Quality and Disparities Report, the
Consumer Assessment of Healthcare
Providers and Systems, Surveys on
Patient Safety Culture programs, and the
AHRQ Quality Indicators.
Center for Financing, Access, and
Cost Trends. Conducts and supports
studies of the use of and expenditures
for health care services, of the sources
of payment for that care, of the
availability and cost of health insurance,
and of access to health care.
Administers surveys and develops large
data sets to support health care policy
and behavioral research and analysis.
The mission includes the production of
the Medical Expenditure Panel Survey
(MEPS) and the Healthcare Cost and
Utilization Project (HCUP).
Shall be organized into the following
four divisions:
Division of Statistical Research and
Methods (DSRM): Responsible for a
wide range of statistical activities (e.g.,
determining sample size and allocation,
data imputation and weighting
strategies) for the design and
implementation of the three
components (household, provider, and
insurance/employer) of MEPS and for
planning and conducting research to
help guide and improve these activities.
Division of Research and Modeling
(DRM): Conducts studies of the access to
and costs and financing of health care
and is responsible for the conduct of
research and the development of models
and databases in support of the overall
mission of AHRQ and CFACT. Provides
ongoing analytic support to MEPS and
HCUP design and implementation.
Develops and maintains various
simulation models, components,
databases, tools, and research products
that enhance the value of the AHRQ
data. Utilizes these models and
databases to conduct microsimulation
analyses of the effects, on households
and individuals, of health policies
embodied in current law, and the
potential effects of health care policies
embodied in generic versions of
proposed health care reforms.
Division of Healthcare Data and
Analytics (DHDA): Leads the
development, production, and
improvement of health care delivery
data and tools for use in research and
policy analysis with a focus on HCUP
and the supply side of the medical care
market. Directs, conducts, and supports
research on health care delivery and
utilization to examine issues related to
E:\FR\FM\19SEN1.SGM
19SEN1
49304
Federal Register / Vol. 84, No. 182 / Thursday, September 19, 2019 / Notices
access, utilization, cost, safety, and
quality of hospital, physician, and other
services. Disseminates data, tools, and
statistics to facilitate and inform public
and private health policy analysis,
clinical studies, and socioeconomic
research to inform public and private
healthcare policy.
Division of Survey Operations (DSO):
Responsible for the MEPS data
collection, processing and distribution
activities. These responsibilities include
directing data collection for the three
major MEPS surveys, preparing data
files for public use, conducting
workshops on the appropriate use of
MEPS data and the development of a
website for disseminating MEPS
products. Publishes statistical briefs,
research findings and a series of
methodological reports. Administers a
data center at which researchers can,
with approved projects and under
specific technical controls and privacy
protocols, access data that cannot be
released to the public for use in specific
research activities. Maintains liaisons
with individuals and organizations
engaged in health services research both
within and outside the federal
government.
All delegations and redelegations of
authority to officers and employees of
the Agency for Healthcare Research and
Quality that were in effect immediately
prior to the effective date of this
reorganization shall continue in effect
pending further redelegation provided
they are consistent with this
reorganization.
These changes are effective upon date
of signature.
Dated: September 18, 2019.
Gopal Khanna,
Director.
[FR Doc. 2019–20218 Filed 9–18–19; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Supplemental Evidence and Data
Request on Therapies for Clinically
Localized Prostate Cancer
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for supplemental
evidence and data submissions.
jbell on DSK3GLQ082PROD with NOTICES
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
the public. Scientific information is
being solicited to inform our review on
SUMMARY:
VerDate Sep<11>2014
17:30 Sep 18, 2019
Jkt 247001
Therapies for Clinically Localized
Prostate Cancer, which is currently
being conducted by the AHRQ’s
Evidence-based Practice Centers (EPC)
Program. Access to published and
unpublished pertinent scientific
information will improve the quality of
this review.
DATES:
Submission Deadline: Comments
must be received on or before 30 days
after date of publication of this notice.
ADDRESSES:
Email submissions: epc@
ahrq.hhs.gov.
Print submissions:
Mailing Address: Center for Evidence
and Practice Improvement, Agency for
Healthcare Research and Quality,
ATTN: EPC SEADs Coordinator, 5600
Fishers Lane, Mail Stop 06E53A,
Rockville, MD 20857.
Shipping Address (FedEx, UPS, etc.):
Center for Evidence and Practice
Improvement, Agency for Healthcare
Research and Quality, ATTN: EPC
SEADs Coordinator, 5600 Fishers Lane,
Mail Stop 06E77D, Rockville, MD
20857.
FOR FURTHER INFORMATION CONTACT:
Jenae Benns, Telephone: 301–427–1496
or Email: epc@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION: The
Agency for Healthcare Research and
Quality has commissioned the
Evidence-based Practice Centers (EPC)
Program to complete a review of the
evidence for Therapies for Clinically
Localized Prostate Cancer. AHRQ is
conducting this systematic review
pursuant to Section 902(a) of the Public
Health Service Act, 42 U.S.C. 299a(a).
The EPC Program is dedicated to
identifying as many studies as possible
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
literature by requesting information
from the public (e.g., details of studies
conducted). We are looking for studies
that report on Therapies for Clinically
Localized Prostate Cancer, including
those that describe adverse events. The
entire research protocol is available
online at: https://
effectivehealthcare.ahrq.gov/products/
prostate-cancer-therapies/protocol.
This is to notify the public that the
EPC Program would find the following
information on Therapies for Clinically
Localized Prostate Cancer helpful:
D A list of completed studies that
your organization has sponsored for this
indication. In the list, please indicate
whether results are available on
ClinicalTrials.gov along with the
ClinicalTrials.gov trial number.
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
D For completed studies that do not
have results on ClinicalTrials.gov, a
summary, including the following
elements: Study number, study period,
design, methodology, indication and
diagnosis, proper use instructions,
inclusion and exclusion criteria,
primary and secondary outcomes,
baseline characteristics, number of
patients screened/eligible/enrolled/lost
to follow-up/withdrawn/analyzed,
effectiveness/efficacy, and safety results.
D A list of ongoing studies that your
organization has sponsored for this
indication. In the list, please provide the
ClinicalTrials.gov trial number or, if the
trial is not registered, the protocol for
the study including a study number, the
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, and primary and secondary
outcomes.
D Description of whether the above
studies constitute ALL Phase II and
above clinical trials sponsored by your
organization for this indication and an
index outlining the relevant information
in each submitted file.
Your contribution is very beneficial to
the Program. Materials submitted must
be publicly available or able to be made
public. Materials that are considered
confidential; marketing materials; study
types not included in the review; or
information on indications not included
in the review cannot be used by the EPC
Program. This is a voluntary request for
information, and all costs for complying
with this request must be borne by the
submitter.
The draft of this review will be posted
on AHRQ’s EPC Program website and
available for public comment for a
period of 4 weeks. If you would like to
be notified when the draft is posted,
please sign up for the email list at:
https://
www.effectivehealthcare.ahrq.gov/
email-updates.
The systematic review will answer the
following questions. This information is
provided as background. AHRQ is not
requesting that the public provide
answers to these questions.
Key Questions
KQ 1: What are the comparative
effectiveness and harms of CLPC
therapies?
(1) Watchful waiting
(2) Active surveillance
(3) Androgen deprivation therapy (ADT)
(4) Focal therapies
(a) Brachytherapy
(b) Cryotherapy
(c) High-intensity focused ultrasound
(HIFU)
(d) Laser ablation
E:\FR\FM\19SEN1.SGM
19SEN1
Agencies
[Federal Register Volume 84, Number 182 (Thursday, September 19, 2019)]
[Notices]
[Pages 49302-49304]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20218]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Statement of Organization, Functions, and Delegations of
Authority
Part E, Chapter E (Agency for Healthcare Research and Quality), of
the Statement of Organization, Functions, and Delegations of Authority
for the Department of Health and Human Services (61 FR 15955-58, April
10, 1996, most recently amended at 81 FR 22271, on April 15, 2016) is
amended to reflect recent organizational changes. The specific
amendments are as follows:
I. Under Section E-10, Organization, delete all components and
replace with the following:
A. Office of the Director.
B. Center for Evidence and Practice Improvement.
C. Center for Quality Improvement and Patient Safety.
D. Center for Financing, Access, and Cost Trends.
E. Office of Communications.
F. Office of Extramural Research, Education, and Priority
Populations.
G. Office of Management Services.
II. Under Section E-20, Functions, delete Center for Evidence and
Practice Improvement, Center for Quality Improvement and Patient
Safety, Center for Delivery, Organization, and Markets, and Center for
Financing Access and Cost Trends in its entirety and replace with the
following:
Center for Evidence and Practice Improvement. Conducts and supports
research on health care delivery and practice improvement across the
continuum of care from prevention to chronic care management to end of
life care. Specifically: (1) Synthesizes evidence and translates
science for multiple stakeholders; (2) advances decision and
communication sciences to facilitate informed treatment and health care
decision making by patients and their health care providers; (3)
explores how health information technology can improve clinical
decision making and health care quality; (4) catalyzes and promotes
sustainability of improvements in clinical practice across health care
settings through research,
[[Page 49303]]
demonstration projects, and partnership development; (5) studies the
roles that health professionals, health systems, and organizations play
in the provision of health care services; (6) examines the role of
health systems in improving quality and efficiency of health care
services; and (7) operates the National Center for Excellence in
Primary Care Research.
Shall be organized into the following five divisions:
Division of Evidence-Based Practice Centers: Produces evidence
syntheses by conducting systematic evidence reviews using robust and
rigorous methodologies and advances the methods of evidence synthesis
to ensure scientific rigor and unbiased reviews.
Division of U.S. Preventive Services Task Force: Provides
scientific, administrative, and dissemination support for the
independent U.S. Preventive Services Task Force, enabling the Task
Force to make evidence-based recommendations on clinical preventive
services.
Division of Digital Healthcare Research: Via advanced analytics to
enhance health care decision making, the division focuses on conducting
research to determine how the parts of the ever evolving digital health
care ecosystem can best come together to affect transformational value
for patients and their families in the safe delivery of care.
Division of Practice Improvement: Advances the science of clinical
practice improvement including shared decision making; evaluates and
supports innovative models of practice transformation in diverse
settings; facilitates communities of learning to promote the
implementation of evidence for practice improvement; and serves as a
trusted source of evidence and tools for methods, measures, and
evaluation of practice improvement.
Division of Healthcare Delivery and Systems Research: Develops new
evidence, tools and measures to understand how health care is delivered
in the U.S., emphasizing the roles that physicians, physician
practices, hospitals, health systems, other medical professionals, and
organizations play in the provision of health care services.
Center for Quality Improvement and Patient Safety. Measures
performance of the U.S. health care system; identifies, promotes, and
supports evidence-based research; and provides information that is used
to improve the safety and quality of health care. Collaborates with
stakeholders across the health care system to: Implement evidence-based
practices, accelerate and amplify improvements in quality and patient
safety.
Shall be organized into the following four divisions:
Division of General Patient Safety: Leads intramural and extramural
research that focuses on the risks and harms inherent in the delivery
of health care for a variety of conditions in all health care settings,
including the hospital, ambulatory and long-term care facilities, and
the home. Develops, tests, and facilitates understanding and use of
evidence-based tools and information to improve the quality and safety
of health care and reduce the risk of patient harm. Major topics of
research and tool development include health care leadership and
teamwork, safe medication use, health care simulation, diagnostic
performance, care coordination, measurement, patient safety reporting
and surveillance, detection and analysis, patient and family
engagement, and health care facility design.
Division of Patient Safety Organizations: Administers the Patient
Safety Organization (PSO) Program in accordance with the Patient Safety
and Quality Improvement Act of 2005. Approves and oversees PSOs that
apply for official federal ``listing.'' Publishes Common Formats for
measuring adverse events in hospitals.
Division of Healthcare-Associated Infections (HAI): Leads AHRQ's
robust program of research studies and implementation projects that has
two closely related purposes: To prevent, reduce, and ultimately
eliminate HAIs; and to combat antibiotic resistance. Fosters the
creation of new knowledge and the generation of evidence to develop
improved methods for preventing health care associated infections and
improving antibiotic use in multiple health care settings, including
hospital acute care, long-term care, and ambulatory care, and promotes
the wide-scale implementation of effective interventions for preventing
healthcare-associated infections and promoting antibiotic stewardship
in all these care settings.
Division of Quality Measurement and Improvement: Conducts quality
measurement and evaluates improvement activities in order to improve
healthcare delivered in the United States. Seeks opportunities to
integrate various measurement efforts in order to provide a more
complete picture of quality and safety. Promotes enhanced collaboration
and coordination of measurement efforts, including integration where
possible, in order to serve the needs of multiple stakeholders who use
measurement, such as front-line clinicians, patients, safety and
quality experts, administrators, researchers, payers, policymakers, and
others. Conducts focused measurement programs including the National
Healthcare Quality and Disparities Report, the Consumer Assessment of
Healthcare Providers and Systems, Surveys on Patient Safety Culture
programs, and the AHRQ Quality Indicators.
Center for Financing, Access, and Cost Trends. Conducts and
supports studies of the use of and expenditures for health care
services, of the sources of payment for that care, of the availability
and cost of health insurance, and of access to health care. Administers
surveys and develops large data sets to support health care policy and
behavioral research and analysis. The mission includes the production
of the Medical Expenditure Panel Survey (MEPS) and the Healthcare Cost
and Utilization Project (HCUP).
Shall be organized into the following four divisions:
Division of Statistical Research and Methods (DSRM): Responsible
for a wide range of statistical activities (e.g., determining sample
size and allocation, data imputation and weighting strategies) for the
design and implementation of the three components (household, provider,
and insurance/employer) of MEPS and for planning and conducting
research to help guide and improve these activities.
Division of Research and Modeling (DRM): Conducts studies of the
access to and costs and financing of health care and is responsible for
the conduct of research and the development of models and databases in
support of the overall mission of AHRQ and CFACT. Provides ongoing
analytic support to MEPS and HCUP design and implementation. Develops
and maintains various simulation models, components, databases, tools,
and research products that enhance the value of the AHRQ data. Utilizes
these models and databases to conduct microsimulation analyses of the
effects, on households and individuals, of health policies embodied in
current law, and the potential effects of health care policies embodied
in generic versions of proposed health care reforms.
Division of Healthcare Data and Analytics (DHDA): Leads the
development, production, and improvement of health care delivery data
and tools for use in research and policy analysis with a focus on HCUP
and the supply side of the medical care market. Directs, conducts, and
supports research on health care delivery and utilization to examine
issues related to
[[Page 49304]]
access, utilization, cost, safety, and quality of hospital, physician,
and other services. Disseminates data, tools, and statistics to
facilitate and inform public and private health policy analysis,
clinical studies, and socioeconomic research to inform public and
private healthcare policy.
Division of Survey Operations (DSO): Responsible for the MEPS data
collection, processing and distribution activities. These
responsibilities include directing data collection for the three major
MEPS surveys, preparing data files for public use, conducting workshops
on the appropriate use of MEPS data and the development of a website
for disseminating MEPS products. Publishes statistical briefs, research
findings and a series of methodological reports. Administers a data
center at which researchers can, with approved projects and under
specific technical controls and privacy protocols, access data that
cannot be released to the public for use in specific research
activities. Maintains liaisons with individuals and organizations
engaged in health services research both within and outside the federal
government.
All delegations and redelegations of authority to officers and
employees of the Agency for Healthcare Research and Quality that were
in effect immediately prior to the effective date of this
reorganization shall continue in effect pending further redelegation
provided they are consistent with this reorganization.
These changes are effective upon date of signature.
Dated: September 18, 2019.
Gopal Khanna,
Director.
[FR Doc. 2019-20218 Filed 9-18-19; 8:45 am]
BILLING CODE 4160-90-P